Kinetic studies of dopamine D2 receptor molecular pharmacologyTools Keen, Alastair C. (2021) Kinetic studies of dopamine D2 receptor molecular pharmacology. PhD thesis, University of Nottingham.
AbstractThe dopamine D2 receptor (D2R) is a G protein-coupled receptor (GPCR) that is the primary target of drugs treating the symptoms of Parkinson’s disease and schizophrenia. However, drugs acting at the D2R to manage these diseases often display efficacy for only a subset of their symptoms and have poor side effect profiles. Therefore, it is desirable to rationally design drugs that better manage disease symptoms and reduce side effects. This would be greatly aided by gaining a detailed understanding of the kinetic aspects of D2R ligand binding, signalling, regulation and trafficking.
Actions (Archive Staff Only)
|